Promoter Methylation of the Retinoic Acid Receptor Beta2 (RARß2) Is Associated with Increased Risk of Breast Cancer: A PRISMA Compliant Meta-Analysis.

Fang, Cheng; Jian, Zhi-Yuan; Shen, Xian-Feng; Wei, Xue-Mei; Yu, Guo-Zheng; Zeng, Xian-Tao

Fang, Cheng; Jian, Zhi-Yuan; Shen, Xian-Feng; Wei, Xue-Mei; Yu, Guo-Zheng; Zeng, Xian-Tao.

Afiliação

Fang C; Center for Evidence-Based Medicine and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jian ZY; Department of General Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Shen XF; Department of General Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Wei XM; Department of Nursing, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, P.R. China.
Yu GZ; Center for Evidence-Based Medicine and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zeng XT; Center for Evidence-Based Medicine and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.

PLoS One ; 10(10): e0140329, 2015.

Article em En | MEDLINE | ID: mdl-26451736

Assuntos

Neoplasias da Mama/genética; Metilação de DNA; Predisposição Genética para Doença/genética; Regiões Promotoras Genéticas/genética; Receptores do Ácido Retinoico/genética; Neoplasias da Mama/patologia; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Regiões Promotoras Genéticas / Receptores do Ácido Retinoico / Metilação de DNA / Predisposição Genética para Doença Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google